138 related articles for article (PubMed ID: 9001837)
1. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
Zuberi SJ; Khan AQ; Irshad-ul-Haque I; Hussain A; Hasnain SS; Shah S; Sadick A; Yusuf MZ; Reuter M
Clin Ther; 1996; 18(6):1207-12. PubMed ID: 9001837
[TBL] [Abstract][Full Text] [Related]
2. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
Fock KM; Kang JY; Ng HS; Ng TM; Gwee KA; Lim CC
J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
[TBL] [Abstract][Full Text] [Related]
3. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
4. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
5. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
6. A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
Walt RP; Logan RF; Hawkey CJ; Daneshmend TK; Long RG; Cooper BT; Langman MJ; Collins M; Street R
Aliment Pharmacol Ther; 1991 Jun; 5(3):301-7. PubMed ID: 1679668
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
Brandstätter G; Marks IN; Lanza F; Kogut D; Cobert B; Savitsky JP; Bender W; Labs R; Wurzer H
Clin Ther; 1995; 17(3):467-78. PubMed ID: 7585851
[TBL] [Abstract][Full Text] [Related]
8. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
Merki HS; Bender W; Labs R
J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
[TBL] [Abstract][Full Text] [Related]
11. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
13. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
Judmaier G
Drugs; 1988; 35 Suppl 3():120-6. PubMed ID: 2905240
[TBL] [Abstract][Full Text] [Related]
14. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
Hentschel E; Schütze K
Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
[TBL] [Abstract][Full Text] [Related]
15. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
17. Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study.
Dobrilla G; De Pretis G; Piazzi L; Boero A; Camarri E; Crespi M; Fontana G; Ideo G; Manenti F; Marenco G
Scand J Gastroenterol Suppl; 1987; 134():21-8. PubMed ID: 2889255
[TBL] [Abstract][Full Text] [Related]
18. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
Bardhan KD; Dekkers CP; Lam SK; Nowak A; Schaffalitzky de Muckadell OB; Schutze K; Tildesley G; Kler L; Forster JK; Lacey LF
Aliment Pharmacol Ther; 1995 Oct; 9(5):497-506. PubMed ID: 8580269
[TBL] [Abstract][Full Text] [Related]
19. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine in the treatment of duodenal ulceration.
Peden NR; Boyd EJ; Saunders JH; Wormsley KG
Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]